Advertisement
Singapore markets close in 3 hours 59 minutes

  • Straits Times Index

    3,168.87
    -18.79 (-0.59%)
     

  • Nikkei

    37,163.50
    -916.20 (-2.41%)
     

  • Hang Seng

    16,184.02
    -201.85 (-1.23%)
     

  • FTSE 100

    7,877.05
    +29.06 (+0.37%)
     

  • Bitcoin USD

    62,432.37
    +786.79 (+1.28%)
     

  • CMC Crypto 200

    1,290.63
    +405.09 (+44.70%)
     

  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     

  • Dow

    37,775.38
    +22.07 (+0.06%)
     

  • Nasdaq

    15,601.50
    -81.87 (-0.52%)
     

  • Gold

    2,398.60
    +0.60 (+0.03%)
     

  • Crude Oil

    84.25
    +1.52 (+1.84%)
     

  • 10-Yr Bond

    4.6470
    +0.0620 (+1.35%)
     

  • FTSE Bursa Malaysia

    1,551.42
    +6.66 (+0.43%)
     

  • Jakarta Composite Index

    7,063.10
    -103.72 (-1.45%)
     

  • PSE Index

    6,411.73
    -111.46 (-1.71%)
     

Infinity: 2Q Earnings Snapshot

Infinity: 2Q Earnings Snapshot

Associated Press

CAMBRIDGE, Mass. (AP) _ Infinity Pharmaceuticals Inc. (INFI) on Tuesday reported a loss of $7 million in its second quarter.

On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 12 cents.

The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 20 cents per share.

In the final minutes of trading on Tuesday, the company's shares hit $1.87. A year ago, they were trading at $1.35.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on INFI at https://www.zacks.com/ap/INFI